查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1929599

髖關節手術器械包市場（按產品、手術技術、材料、應用和最終用戶分類），全球預測，2026-2032年

Hip Surgery Instrument Set Market by Product Type, Surgical Technique, Material, Application, End User - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 193 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

2025年髖關節手術器械套裝市值為8.7984億美元，預計到2026年將成長至9.4475億美元，年複合成長率為6.81%，到2032年將達到13.9537億美元。

主要市場統計數據
基準年 2025 8.7984億美元
預計年份：2026年 9.4475億美元
預測年份：2032年 13.9537億美元
複合年成長率 (%) 6.81%

本文從策略角度概述了在現代醫療保健環境中重塑髖關節手術器械採購和使用的臨床、營運和供應鏈促進因素。

在現代整形外科醫療中，髖關節手術器械是影響臨床療效、手術效率和供應鏈韌性的關鍵因素。臨床醫生日益要求器械能夠在有限的手術時間內支援精準的操作，而醫療機構則需要在滿足這些臨床需求的同時，兼顧成本壓力和消毒物流。本報告概述了器械結構、材料選擇以及不斷變化的手術流程如何共同影響各類醫療機構的採購、培訓和長期資產管理決策。

臨床創新、材料技術進步和不斷變化的醫療服務模式如何推動髖關節手術器材的重新設計和新的籌資策略

髖關節整形外科領域經歷了許多變革，徹底改變了器械的設計、應用和管理方式。微創手術和機器人輔助平台的興起，重新定義了器械的人體工學和模組化要求，推動了對更纖薄、更精準且可與導航系統整合的器械和附件的需求。同時，門診手術中心和門診髖關節手術計畫的蓬勃發展，也促使製造商生產兼具便攜性和全面手術功能的器械套裝，使小規模的醫療機構能夠在不影響安全性的前提下開展複雜的手術。

評估2025年關稅調整以及不斷變化的貿易措施對外科設備供應商的採購、成本動態和供應鏈韌性的影響

2025計劃和貿易措施，特別是影響醫療設備原料和成品的關稅調整，為全球供應鏈帶來了更多複雜性。對鈦等原料和某些成品徵收的關稅增加了部分製造商的到岸成本，促使他們調整策略採購策略，並重新聚焦於關鍵零件的本地生產。由於合約條款需要修訂以反映新的關稅和物流限制，這些措施對採購計劃和供應商談判產生了連鎖反應。

臨床和採購的考量細分為產品類型、適應症、最終用戶環境、手術方法和材料偏好等，這些因素都會影響器械套裝的設計。

對細分市場的深入理解有助於明確器械套裝在不同細分市場（包括產品類型、臨床應用、終端用戶環境、手術技術和材料偏好）中必須滿足的不同需求。產品類型包括擴孔器、髖臼杯、銼刀、擴孔鑽和原型人工替代物。髖臼杯可再分為骨水泥型、混合型和非骨水泥型，而擴孔鑽則細分為髀臼和股骨擴孔鑽。每個產品子類別都有其獨特的尺寸公差、表面光潔度和器械操作流程，這些都會影響器械套裝的配置和滅菌通訊協定。

區域採購模式、監管差異以及先進外科技術的採用如何影響美洲、歐洲、中東、非洲和亞太地區的器械優先事項？

區域趨勢對髖關節手術器械包的籌資策略、供應商關係發展以及技術創新應用有顯著影響。在美洲，成熟的醫院網路和日趨完善的門診手術中心市場對可重複使用的器械包和一次性輔助器具的需求強勁，促使醫療機構越來越關注生命週期管理合約和服務模式，從而簡化資產管理。北美醫療機構也傾向於優先考慮快速獲取機器人輔助和導航技術的創新成果，這推動了對早期採用和相容器材的需求。

為什麼那些將精密儀器、檢驗的滅菌支持、材料創新和一體化服務模式相結合的公司能夠贏得長期採購合約

髖關節手術器械包生態系統中的領導企業正從單純的產品供應轉型為提供包含器械和臨床培訓服務協議的整合解決方案。那些擁有經過檢驗的滅菌流程、可互通的托盤系統和完善的備件供應體系的製造商，正成為重視可預測性和運作的大型醫療機構的首選。隨著提供端到端手術生態系統（而非獨立工具）的趨勢加速發展，器械製造商、手術機器人公司和導航軟體供應商之間的策略聯盟也日益普遍。

為醫療設備製造商和醫療系統提供切實可行的策略性舉措，透過模組化設計、材料策略和穩健的採購模式，使其儀器產品組合面向未來。

產業領導者應優先考慮以下五個切實可行的步驟，以建立能夠應對不斷變化的臨床、監管和供應鏈現實的器械包組合。首先，投資於模組化器械包架構，最大限度地減少托盤數量，從而降低滅菌量和儲存需求，同時能夠快速重新配置以適應大型手術和翻修手術。其次，將鈦和先進不銹鋼合金的選擇性使用納入材料策略，以平衡外科醫生對手術操作性能的要求與高強度使用環境所需的耐用性。

結合臨床訪談、供應鏈分析、材料審查和專家檢驗的嚴謹混合方法，可為您的器材策略提供切實可行的見解。

本研究的結論是基於混合研究方法，整合了定性訪談、有針對性的二手研究以及臨床、採購和供應鏈來源之間的三角驗證。主要研究包括對骨科醫生、消毒供應中心經理、醫院和門診中心採購主管以及產品開發主管的深入訪談；這些訪談提供了關於器械人體工學、托盤配置偏好和再處理挑戰的實用見解。

整合關鍵的臨床、營運和供應鏈問題，以確定哪些儀器策略能夠提供持續的臨床效能和營運韌性。

髖關節手術器械市場正處於轉折點，臨床創新、材料選擇和供應鏈策略的交匯點將決定手術效率和採購結果。微創手術和機器人輔助手術的發展趨勢要求器械組合必須互通性、符合人體工學，並與現代工作流程相容。同時，關稅和區域採購差異帶來的供應鏈壓力要求檢驗的籌資策略和本地化的服務能力，以維持供應的連續性和手術效率。

目錄

第1章：序言

第2章調查方法

  • 研究設計
  • 研究框架
  • 市場規模預測
  • 數據三角測量
  • 調查結果
  • 調查前提
  • 調查限制

第3章執行摘要

  • 首席主管觀點
  • 市場規模和成長趨勢
  • 2025年市佔率分析
  • FPNV定位矩陣，2025
  • 新的商機
  • 下一代經營模式
  • 產業藍圖

第4章 市場概覽

  • 產業生態系與價值鏈分析
  • 波特五力分析
  • PESTEL 分析
  • 市場展望
  • 上市策略

第5章 市場洞察

  • 消費者洞察與終端用戶觀點
  • 消費者體驗基準
  • 機會地圖
  • 分銷通路分析
  • 價格趨勢分析
  • 監理合規和標準框架
  • ESG與永續性分析
  • 中斷和風險情景
  • 投資報酬率和成本效益分析

第6章 美國關稅的累積影響，2025年

第7章 人工智慧的累積影響，2025年

第8章 按產品類型分類的髖關節手術器械套裝市場

  • 胸針
  • 杯子
    • 水泥固定
    • 混合
    • 非水泥型
  • 銼刀
  • 擴孔器
    • 髀臼
    • 股骨
  • 用於測試的人工關節

9. 依手術技術分類的髖關節手術器械套裝市場

  • 微創手術
    • 前路入路
    • 側入路
    • 後路入路
  • 機器人輔助
  • 傳統方法

第10章 按材料分類的髖關節手術器械套裝市場

  • 免洗塑膠
  • 防鏽的
  • 鈦

第11章 按應用分類的髖關節手術器械套裝市場

  • 初次髖關節置換術
  • 髖重新置換置換術
    • 部分置換術
    • 全置換術

第12章 依最終用戶分類的髖關節手術器械套裝市場

  • 門診手術中心
  • 醫院
  • 專業整形外科診所

第13章 各地區髖關節手術器械套裝市場

  • 美洲
    • 北美洲
    • 拉丁美洲
  • 歐洲、中東和非洲
    • 歐洲
    • 中東
    • 非洲
  • 亞太地區

第14章 髖關節手術器械套裝市場（按類別分類）

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第15章 各國髖關節手術器械套裝市場

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第16章 美國髖關節手術器械套裝市場

第17章 中國髖關節手術器材套裝市場

第18章 競爭格局

  • 市場集中度分析，2025年
    • 濃度比（CR）
    • 赫芬達爾-赫希曼指數 (HHI)
  • 近期趨勢及影響分析，2025 年
  • 2025年產品系列分析
  • 基準分析，2025 年
  • Acumed LLC
  • Aesculap, Inc.
  • Arthrex, Inc.
  • B. Braun Melsungen AG
  • Conmed Corporation
  • DJO, LLC
  • Exactech, Inc.
  • HipInnovation LLC
  • Integra LifeSciences Corporation
  • Medacta International SA
  • Medtronic plc
  • MicroPort Orthopedics, Inc.
  • MicroPort Scientific Corporation
  • Orthofix Medical Inc.
  • Smith & Nephew plc
  • Stryker Corporation
  • Trauson Holdings Co., Ltd.
  • Wright Medical Group NV
  • Zimmer Biomet Holdings, Inc.
  • Zimmer, Inc.
Product Code: MRR-0A3806951842

The Hip Surgery Instrument Set Market was valued at USD 879.84 million in 2025 and is projected to grow to USD 944.75 million in 2026, with a CAGR of 6.81%, reaching USD 1,395.37 million by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 879.84 million
Estimated Year [2026] USD 944.75 million
Forecast Year [2032] USD 1,395.37 million
CAGR (%) 6.81%

A strategic overview framing clinical, operational, and supply chain drivers that are reshaping procurement and use of hip surgery instrument sets in modern care settings

Hip surgery instrument sets occupy a critical nexus between clinical outcomes, procedural efficiency, and supply chain resilience within contemporary orthopedic care. Clinicians increasingly demand instruments that support precision techniques while operating within constrained procedural windows, and institutions balance those clinical requirements against cost pressures and sterilization logistics. This report synthesizes how instrument architecture, material choices, and evolving surgical workflows collectively influence procurement, training, and long-term asset management decisions across provider types.

Stakeholders that influence instrument set selection span surgeons, perioperative nurses, sterile processing teams, hospital procurement, and ambulatory surgery administrators. Each constituency brings unique performance criteria: surgeons prioritize ergonomics and tactile feedback, sterile processing teams emphasize reprocessing durability and tracking, and procurement views lifecycle cost and supplier reliability as primary determinants. Understanding these intersecting priorities clarifies why a one-size-fits-all approach to instrument sets no longer suffices and why modular, interoperable solutions are gaining traction.

The narrative that follows explores how shifts in surgical technique, materials innovation, regulatory scrutiny, and trade dynamics reshape the landscape for hip surgery instrument sets. By anchoring the analysis in practical operational realities and recent technological adoption patterns, readers will gain a structured view of the risks and opportunities that should inform near-term investment and procurement decisions.

How clinical innovations, material advances, and shifting care delivery patterns are compelling redesign and new procurement strategies for hip surgery instrument sets

The orthopedics landscape for hip procedures has undergone several transformative shifts that are changing how instrument sets are designed, deployed, and managed. Minimally invasive approaches and the rise of robot-assisted platforms have redefined instrument ergonomics and modularity requirements, driving demand for slimmer, more precise instruments and attachments that integrate with navigation systems. Concurrently, the growth of ambulatory surgery centers and outpatient hip programs has pressured manufacturers to produce instrument sets that balance portability with comprehensive procedural functionality, allowing smaller sites to perform complex cases without compromising safety.

Material innovation continues to be a decisive factor. Advances in stainless steel metallurgy and the broader adoption of titanium for specific components have enhanced durability and reduced instrument weight, while the increased use of disposable plastics for selected single-use items mitigates reprocessing risk and turnaround constraints. Regulatory emphasis on traceability and sterilization validation has pushed suppliers to embed unique device identification, sterilization cycle compatibility, and validated maintenance instructions into product documentation and service offerings.

This period also features a pronounced focus on sustainability and total cost of ownership within procurement cycles. Healthcare systems are increasingly evaluating the environmental and operational footprint of reusable versus disposable components, balancing infection control priorities with lifecycle implications. Taken together, these shifts are prompting more strategic collaboration between clinicians, hospital administrators, and suppliers to co-design instrument portfolios that meet clinical objectives while optimizing logistical and financial performance.

Assessment of 2025 tariff adjustments and how evolving trade measures are altering sourcing, cost dynamics, and supply chain resilience for surgical instrument suppliers

Policy and trade actions in 2025, including tariff adjustments affecting medical device inputs and finished instruments, have introduced an additional layer of complexity across global supply chains. Tariffs on raw materials such as titanium and on certain finished goods have increased landed costs for some manufacturers, prompting strategic sourcing adjustments and renewed emphasis on localized manufacturing for critical components. These measures have had cascading effects across procurement timelines and supplier negotiations, as contract terms are revisited to reflect new duties and logistics constraints.

Hospitals and ambulatory centers responded by intensifying supplier diversification efforts and by accelerating conversations about total lifecycle costs. Purchasing teams are increasingly seeking flexible pricing structures, multi-year agreements with tariff pass-through clauses, and inventory strategies that can buffer short-term tariff volatility. In parallel, some manufacturers have sought to redesign instrument kits to reduce reliance on tariff-affected components, substitute materials where clinically appropriate, and qualify alternative vendors in lower-tariff jurisdictions to stabilize supply.

The tariff-driven recalibration has also influenced decisions around disposable versus reusable components. Where duties make imported reusable components more costly, single-use alternatives-sourced domestically or from preferential trade partners-have become more attractive despite differing environmental and waste-management considerations. Ultimately, organizations that proactively integrated tariff scenarios into procurement planning and that maintained flexible supplier networks were better positioned to mitigate disruption and preserve procedural throughput.

Segmented clinical and procurement considerations across product types, procedural indications, end-user settings, surgical access approaches, and material preferences influencing instrument set design

A granular understanding of segmentation clarifies the divergent needs that instrument sets must satisfy across product categories, clinical applications, end-user environments, surgical techniques, and material preferences. Product-type differentiation encompasses broaches, cups, rasps, reamers, and trial prostheses, with cups further delineated into cemented, hybrid, and uncemented variants and reamers subdivided into acetabular and femoral designs. Each product subcategory imposes distinct dimensional tolerances, surface finishes, and instrumentation workflows that influence set composition and sterilization protocols.

On the application axis, primary hip replacement and revision hip replacement create distinct procedural demands: revision work, whether partial or total, often requires expanded instrument inventories and adaptable trialing components to address varied bone loss patterns and implant compatibility challenges. End-user environments-ambulatory surgery centers, hospitals, and specialized orthopedic clinics-differ in storage capacity, sterilization infrastructure, and procedural volume, which in turn dictate preferences for modular trays, compact instrument kits, or expanded case carts.

Surgical technique further shapes instrument design priorities. Minimally invasive approaches, including anterior, lateral, and posterior access routes, increase demand for low-profile instruments and optimized retraction systems, while robot-assisted workflows necessitate instrument interfaces compatible with guidance platforms and navigation. Traditional access continues to require robust, reusable instruments with proven longevity. Material choice completes the segmentation picture: disposable plastics, stainless steel, and titanium each present trade-offs in weight, durability, reprocessing complexity, and cost that procurement and clinical teams must reconcile when specifying instrument sets.

How regional procurement models, regulatory variability, and adoption of advanced surgical techniques are shaping instrument set priorities across Americas, EMEA, and Asia-Pacific

Regional dynamics materially influence procurement strategies, supplier relationships, and innovation adoption for hip surgery instrument sets. In the Americas, established hospital networks and a mature ambulatory surgery center market create strong demand for both reusable instrument suites and single-use adjuncts, with institutions showing heightened interest in lifecycle management agreements and service-based models that simplify asset maintenance. North American providers also tend to prioritize rapid access to innovations in robotic assistance and navigation, driving early adoption and associated demand for compatible instruments.

Europe, the Middle East, and Africa present a heterogeneous mix of regulatory regimes and procurement practices where some markets emphasize centralized purchasing and strict sterilization standards, while others prioritize cost containment and local production. In this broad region, partnerships between international suppliers and regional distributors are crucial for navigating complex reimbursement landscapes and for ensuring consistent training and support for advanced surgical techniques.

Asia-Pacific exhibits substantial variation across high-volume urban centers and emerging regional markets. Providers in advanced centers are rapidly integrating robot-assisted systems and minimally invasive approaches, increasing demand for specialized instrument interfaces and precision components, while other markets emphasize cost-effective, durable instruments that can withstand high utilization rates and intermittent sterilization capacity. Across all regions, localized manufacturing, robust distribution networks, and tailored training programs remain critical enablers of successful instrument set deployment.

Why companies that combine precision instrumentation, validated sterilization support, materials innovation, and integrated service models are winning long-term procurement commitments

Leading companies in the hip surgery instrument set ecosystem are evolving beyond commodity supply to offer integrated solutions that combine instrumentation, clinical training, and service contracts. Manufacturers that differentiate through validated sterilization instructions, interoperable tray systems, and robust spare-part programs gain preference among large health systems that value predictability and uptime. Strategic partnerships between instrument makers, surgical robotics firms, and navigation software providers are increasingly common as companies seek to offer end-to-end procedural ecosystems rather than standalone tools.

Supply-side consolidation and vertical integration are also visible, with some firms investing in localized manufacturing and expanded service footprints to protect against trade and logistics disruptions. Companies that invest in materials science-optimizing stainless steel alloys and selectively applying titanium to reduce weight while maintaining strength-position their portfolios to meet surgeon demands for tactile performance and longevity. Meanwhile, manufacturers that embrace sterilization science and provide validated reprocessing cycles, training for sterile processing teams, and digital tracking solutions enhance clinical confidence and minimize lifecycle risk.

Distribution partners and service providers that offer inventory management, tray reconfiguration services, and modular kit design support further differentiate themselves in competitive procurement cycles. Firms that align product roadmaps with surgeon feedback loops and deliver timely clinical education are more likely to secure long-term framework agreements with hospitals and ambulatory centers.

Actionable strategic initiatives for device makers and health systems to future-proof instrument portfolios through modular design, materials strategy, and resilient sourcing models

Industry leaders should prioritize five pragmatic initiatives to align instrument set portfolios with evolving clinical, regulatory, and supply chain realities. First, invest in modular kit architectures that allow rapid reconfiguration for primary and revision procedures while minimizing tray counts to reduce sterilization throughput and storage demands. Second, expand materials strategy to include selective use of titanium and advanced stainless alloys to balance surgeon preferences for performance with the durability required for high-volume environments.

Third, develop flexible sourcing and manufacturing footprints that mitigate tariff and logistics volatility by qualifying alternate suppliers and establishing regional production capabilities for critical components. Fourth, deepen service offerings by providing validated reprocessing instructions, digital tracking for instrument lifecycle management, and training programs tailored to both surgical and sterile processing teams, which together reduce risk and improve OR efficiency. Finally, collaborate with clinical partners and robotics/navigation vendors to ensure instrument interfaces support emerging surgical workflows, investing in co-development where appropriate to accelerate adoption.

Implementing these actions demands cross-functional alignment between R&D, commercial, and operations teams, as well as structured feedback loops with frontline clinicians. Organizations that take a proactive, systems-oriented approach will be better positioned to capture procedural preferences, control lifecycle costs, and sustain competitive differentiation in an environment defined by rapid technological and policy shifts.

A rigorous mixed-methods approach combining clinical interviews, supply chain analysis, materials review, and expert validation to underpin actionable insights for instrument strategy

This study's conclusions derive from a mixed-methods research approach that integrated primary qualitative interviews, targeted secondary research, and triangulation across clinical, procurement, and supply chain sources. Primary research included in-depth interviews with orthopedic surgeons, sterile processing managers, procurement leaders at hospitals and ambulatory centers, and product development executives; these conversations informed practical insights on instrument ergonomics, tray configuration preferences, and reprocessing challenges.

Secondary analysis encompassed regulatory guidance, clinical literature on surgical approaches and outcomes, materials science publications related to instrument metallurgy, and publicly available manufacturer technical documentation. Supply chain analysis examined trade policy changes, tariff schedules, and logistics constraints as they affect component sourcing and landed costs, while case studies of procurement decisions provided real-world examples of mitigation strategies used by providers.

Throughout the research process, findings were validated via cross-stakeholder workshops and expert review sessions to ensure that conclusions reflect operational realities. Data integrity measures included source triangulation, methodological transparency, and iterative review with clinical experts to align technical descriptions with practical surgical workflows. This layered methodology supports robust, actionable insights that inform procurement, product development, and strategic planning.

Synthesis of clinical, operational, and supply chain imperatives that will determine which instrument strategies deliver sustained clinical performance and operational resilience

The hip surgery instrument set landscape is at an inflection point where clinical innovation, material selection, and supply chain strategy intersect to determine procedural efficiency and procurement outcomes. Surgical trends toward minimally invasive and robot-assisted procedures demand instrument portfolios that are interoperable, ergonomically optimized, and validated for modern workflows. At the same time, tariff-induced supply chain pressures and regional procurement differences require flexible sourcing strategies and localized service capabilities to maintain continuity of supply and procedural throughput.

Successful stakeholders will be those who take a systems-oriented view: aligning product design with sterilization workflows, embedding validated reprocessing instructions, and offering modular kit solutions that reduce OR complexity. Companies that invest in materials innovation and build resilient, regionally diversified manufacturing footprints will be better insulated from trade and logistics shocks. For providers, prioritizing partnerships that deliver training, after-sales support, and digital lifecycle management will yield measurable gains in efficiency and clinical confidence.

In sum, intentional collaboration among clinicians, procurement, and suppliers-backed by robust data and flexible commercial models-will be essential to unlocking sustained improvements in hip surgery outcomes and operational performance.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Hip Surgery Instrument Set Market, by Product Type

  • 8.1. Broaches
  • 8.2. Cups
    • 8.2.1. Cemented
    • 8.2.2. Hybrid
    • 8.2.3. Uncemented
  • 8.3. Rasps
  • 8.4. Reamers
    • 8.4.1. Acetabular
    • 8.4.2. Femoral
  • 8.5. Trial Prosthesis

9. Hip Surgery Instrument Set Market, by Surgical Technique

  • 9.1. Minimally Invasive
    • 9.1.1. Anterior
    • 9.1.2. Lateral
    • 9.1.3. Posterior
  • 9.2. Robot Assisted
  • 9.3. Traditional Access

10. Hip Surgery Instrument Set Market, by Material

  • 10.1. Disposable Plastics
  • 10.2. Stainless Steel
  • 10.3. Titanium

11. Hip Surgery Instrument Set Market, by Application

  • 11.1. Primary Hip Replacement
  • 11.2. Revision Hip Replacement
    • 11.2.1. Partial Revision
    • 11.2.2. Total Revision

12. Hip Surgery Instrument Set Market, by End User

  • 12.1. Ambulatory Surgery Centers
  • 12.2. Hospitals
  • 12.3. Specialized Orthopedic Clinics

13. Hip Surgery Instrument Set Market, by Region

  • 13.1. Americas
    • 13.1.1. North America
    • 13.1.2. Latin America
  • 13.2. Europe, Middle East & Africa
    • 13.2.1. Europe
    • 13.2.2. Middle East
    • 13.2.3. Africa
  • 13.3. Asia-Pacific

14. Hip Surgery Instrument Set Market, by Group

  • 14.1. ASEAN
  • 14.2. GCC
  • 14.3. European Union
  • 14.4. BRICS
  • 14.5. G7
  • 14.6. NATO

15. Hip Surgery Instrument Set Market, by Country

  • 15.1. United States
  • 15.2. Canada
  • 15.3. Mexico
  • 15.4. Brazil
  • 15.5. United Kingdom
  • 15.6. Germany
  • 15.7. France
  • 15.8. Russia
  • 15.9. Italy
  • 15.10. Spain
  • 15.11. China
  • 15.12. India
  • 15.13. Japan
  • 15.14. Australia
  • 15.15. South Korea

16. United States Hip Surgery Instrument Set Market

17. China Hip Surgery Instrument Set Market

18. Competitive Landscape

  • 18.1. Market Concentration Analysis, 2025
    • 18.1.1. Concentration Ratio (CR)
    • 18.1.2. Herfindahl Hirschman Index (HHI)
  • 18.2. Recent Developments & Impact Analysis, 2025
  • 18.3. Product Portfolio Analysis, 2025
  • 18.4. Benchmarking Analysis, 2025
  • 18.5. Acumed LLC
  • 18.6. Aesculap, Inc.
  • 18.7. Arthrex, Inc.
  • 18.8. B. Braun Melsungen AG
  • 18.9. Conmed Corporation
  • 18.10. DJO, LLC
  • 18.11. Exactech, Inc.
  • 18.12. HipInnovation LLC
  • 18.13. Integra LifeSciences Corporation
  • 18.14. Medacta International SA
  • 18.15. Medtronic plc
  • 18.16. MicroPort Orthopedics, Inc.
  • 18.17. MicroPort Scientific Corporation
  • 18.18. Orthofix Medical Inc.
  • 18.19. Smith & Nephew plc
  • 18.20. Stryker Corporation
  • 18.21. Trauson Holdings Co., Ltd.
  • 18.22. Wright Medical Group N.V.
  • 18.23. Zimmer Biomet Holdings, Inc.
  • 18.24. Zimmer, Inc.

LIST OF FIGURES

  • FIGURE 1. GLOBAL HIP SURGERY INSTRUMENT SET MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL HIP SURGERY INSTRUMENT SET MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL HIP SURGERY INSTRUMENT SET MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL HIP SURGERY INSTRUMENT SET MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL HIP SURGERY INSTRUMENT SET MARKET SIZE, BY SURGICAL TECHNIQUE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL HIP SURGERY INSTRUMENT SET MARKET SIZE, BY MATERIAL, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL HIP SURGERY INSTRUMENT SET MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL HIP SURGERY INSTRUMENT SET MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL HIP SURGERY INSTRUMENT SET MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL HIP SURGERY INSTRUMENT SET MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 11. GLOBAL HIP SURGERY INSTRUMENT SET MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 12. UNITED STATES HIP SURGERY INSTRUMENT SET MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 13. CHINA HIP SURGERY INSTRUMENT SET MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL HIP SURGERY INSTRUMENT SET MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL HIP SURGERY INSTRUMENT SET MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL HIP SURGERY INSTRUMENT SET MARKET SIZE, BY BROACHES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL HIP SURGERY INSTRUMENT SET MARKET SIZE, BY BROACHES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL HIP SURGERY INSTRUMENT SET MARKET SIZE, BY BROACHES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL HIP SURGERY INSTRUMENT SET MARKET SIZE, BY CUPS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL HIP SURGERY INSTRUMENT SET MARKET SIZE, BY CUPS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL HIP SURGERY INSTRUMENT SET MARKET SIZE, BY CUPS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL HIP SURGERY INSTRUMENT SET MARKET SIZE, BY CUPS, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL HIP SURGERY INSTRUMENT SET MARKET SIZE, BY CEMENTED, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL HIP SURGERY INSTRUMENT SET MARKET SIZE, BY CEMENTED, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL HIP SURGERY INSTRUMENT SET MARKET SIZE, BY CEMENTED, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL HIP SURGERY INSTRUMENT SET MARKET SIZE, BY HYBRID, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL HIP SURGERY INSTRUMENT SET MARKET SIZE, BY HYBRID, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL HIP SURGERY INSTRUMENT SET MARKET SIZE, BY HYBRID, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL HIP SURGERY INSTRUMENT SET MARKET SIZE, BY UNCEMENTED, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL HIP SURGERY INSTRUMENT SET MARKET SIZE, BY UNCEMENTED, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL HIP SURGERY INSTRUMENT SET MARKET SIZE, BY UNCEMENTED, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL HIP SURGERY INSTRUMENT SET MARKET SIZE, BY RASPS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL HIP SURGERY INSTRUMENT SET MARKET SIZE, BY RASPS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL HIP SURGERY INSTRUMENT SET MARKET SIZE, BY RASPS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL HIP SURGERY INSTRUMENT SET MARKET SIZE, BY REAMERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL HIP SURGERY INSTRUMENT SET MARKET SIZE, BY REAMERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL HIP SURGERY INSTRUMENT SET MARKET SIZE, BY REAMERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL HIP SURGERY INSTRUMENT SET MARKET SIZE, BY REAMERS, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL HIP SURGERY INSTRUMENT SET MARKET SIZE, BY ACETABULAR, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL HIP SURGERY INSTRUMENT SET MARKET SIZE, BY ACETABULAR, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL HIP SURGERY INSTRUMENT SET MARKET SIZE, BY ACETABULAR, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL HIP SURGERY INSTRUMENT SET MARKET SIZE, BY FEMORAL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL HIP SURGERY INSTRUMENT SET MARKET SIZE, BY FEMORAL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL HIP SURGERY INSTRUMENT SET MARKET SIZE, BY FEMORAL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL HIP SURGERY INSTRUMENT SET MARKET SIZE, BY TRIAL PROSTHESIS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL HIP SURGERY INSTRUMENT SET MARKET SIZE, BY TRIAL PROSTHESIS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL HIP SURGERY INSTRUMENT SET MARKET SIZE, BY TRIAL PROSTHESIS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL HIP SURGERY INSTRUMENT SET MARKET SIZE, BY SURGICAL TECHNIQUE, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL HIP SURGERY INSTRUMENT SET MARKET SIZE, BY MINIMALLY INVASIVE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL HIP SURGERY INSTRUMENT SET MARKET SIZE, BY MINIMALLY INVASIVE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL HIP SURGERY INSTRUMENT SET MARKET SIZE, BY MINIMALLY INVASIVE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL HIP SURGERY INSTRUMENT SET MARKET SIZE, BY MINIMALLY INVASIVE, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL HIP SURGERY INSTRUMENT SET MARKET SIZE, BY ANTERIOR, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL HIP SURGERY INSTRUMENT SET MARKET SIZE, BY ANTERIOR, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL HIP SURGERY INSTRUMENT SET MARKET SIZE, BY ANTERIOR, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL HIP SURGERY INSTRUMENT SET MARKET SIZE, BY LATERAL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL HIP SURGERY INSTRUMENT SET MARKET SIZE, BY LATERAL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL HIP SURGERY INSTRUMENT SET MARKET SIZE, BY LATERAL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL HIP SURGERY INSTRUMENT SET MARKET SIZE, BY POSTERIOR, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL HIP SURGERY INSTRUMENT SET MARKET SIZE, BY POSTERIOR, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL HIP SURGERY INSTRUMENT SET MARKET SIZE, BY POSTERIOR, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL HIP SURGERY INSTRUMENT SET MARKET SIZE, BY ROBOT ASSISTED, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL HIP SURGERY INSTRUMENT SET MARKET SIZE, BY ROBOT ASSISTED, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL HIP SURGERY INSTRUMENT SET MARKET SIZE, BY ROBOT ASSISTED, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL HIP SURGERY INSTRUMENT SET MARKET SIZE, BY TRADITIONAL ACCESS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL HIP SURGERY INSTRUMENT SET MARKET SIZE, BY TRADITIONAL ACCESS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL HIP SURGERY INSTRUMENT SET MARKET SIZE, BY TRADITIONAL ACCESS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL HIP SURGERY INSTRUMENT SET MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL HIP SURGERY INSTRUMENT SET MARKET SIZE, BY DISPOSABLE PLASTICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL HIP SURGERY INSTRUMENT SET MARKET SIZE, BY DISPOSABLE PLASTICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL HIP SURGERY INSTRUMENT SET MARKET SIZE, BY DISPOSABLE PLASTICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL HIP SURGERY INSTRUMENT SET MARKET SIZE, BY STAINLESS STEEL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL HIP SURGERY INSTRUMENT SET MARKET SIZE, BY STAINLESS STEEL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL HIP SURGERY INSTRUMENT SET MARKET SIZE, BY STAINLESS STEEL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL HIP SURGERY INSTRUMENT SET MARKET SIZE, BY TITANIUM, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL HIP SURGERY INSTRUMENT SET MARKET SIZE, BY TITANIUM, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 64. GLOBAL HIP SURGERY INSTRUMENT SET MARKET SIZE, BY TITANIUM, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 65. GLOBAL HIP SURGERY INSTRUMENT SET MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 66. GLOBAL HIP SURGERY INSTRUMENT SET MARKET SIZE, BY PRIMARY HIP REPLACEMENT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 67. GLOBAL HIP SURGERY INSTRUMENT SET MARKET SIZE, BY PRIMARY HIP REPLACEMENT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 68. GLOBAL HIP SURGERY INSTRUMENT SET MARKET SIZE, BY PRIMARY HIP REPLACEMENT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 69. GLOBAL HIP SURGERY INSTRUMENT SET MARKET SIZE, BY REVISION HIP REPLACEMENT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 70. GLOBAL HIP SURGERY INSTRUMENT SET MARKET SIZE, BY REVISION HIP REPLACEMENT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 71. GLOBAL HIP SURGERY INSTRUMENT SET MARKET SIZE, BY REVISION HIP REPLACEMENT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 72. GLOBAL HIP SURGERY INSTRUMENT SET MARKET SIZE, BY REVISION HIP REPLACEMENT, 2018-2032 (USD MILLION)
  • TABLE 73. GLOBAL HIP SURGERY INSTRUMENT SET MARKET SIZE, BY PARTIAL REVISION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 74. GLOBAL HIP SURGERY INSTRUMENT SET MARKET SIZE, BY PARTIAL REVISION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 75. GLOBAL HIP SURGERY INSTRUMENT SET MARKET SIZE, BY PARTIAL REVISION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 76. GLOBAL HIP SURGERY INSTRUMENT SET MARKET SIZE, BY TOTAL REVISION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 77. GLOBAL HIP SURGERY INSTRUMENT SET MARKET SIZE, BY TOTAL REVISION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 78. GLOBAL HIP SURGERY INSTRUMENT SET MARKET SIZE, BY TOTAL REVISION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 79. GLOBAL HIP SURGERY INSTRUMENT SET MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 80. GLOBAL HIP SURGERY INSTRUMENT SET MARKET SIZE, BY AMBULATORY SURGERY CENTERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 81. GLOBAL HIP SURGERY INSTRUMENT SET MARKET SIZE, BY AMBULATORY SURGERY CENTERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 82. GLOBAL HIP SURGERY INSTRUMENT SET MARKET SIZE, BY AMBULATORY SURGERY CENTERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 83. GLOBAL HIP SURGERY INSTRUMENT SET MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 84. GLOBAL HIP SURGERY INSTRUMENT SET MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 85. GLOBAL HIP SURGERY INSTRUMENT SET MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 86. GLOBAL HIP SURGERY INSTRUMENT SET MARKET SIZE, BY SPECIALIZED ORTHOPEDIC CLINICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 87. GLOBAL HIP SURGERY INSTRUMENT SET MARKET SIZE, BY SPECIALIZED ORTHOPEDIC CLINICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 88. GLOBAL HIP SURGERY INSTRUMENT SET MARKET SIZE, BY SPECIALIZED ORTHOPEDIC CLINICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 89. GLOBAL HIP SURGERY INSTRUMENT SET MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 90. AMERICAS HIP SURGERY INSTRUMENT SET MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 91. AMERICAS HIP SURGERY INSTRUMENT SET MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 92. AMERICAS HIP SURGERY INSTRUMENT SET MARKET SIZE, BY CUPS, 2018-2032 (USD MILLION)
  • TABLE 93. AMERICAS HIP SURGERY INSTRUMENT SET MARKET SIZE, BY REAMERS, 2018-2032 (USD MILLION)
  • TABLE 94. AMERICAS HIP SURGERY INSTRUMENT SET MARKET SIZE, BY SURGICAL TECHNIQUE, 2018-2032 (USD MILLION)
  • TABLE 95. AMERICAS HIP SURGERY INSTRUMENT SET MARKET SIZE, BY MINIMALLY INVASIVE, 2018-2032 (USD MILLION)
  • TABLE 96. AMERICAS HIP SURGERY INSTRUMENT SET MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 97. AMERICAS HIP SURGERY INSTRUMENT SET MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 98. AMERICAS HIP SURGERY INSTRUMENT SET MARKET SIZE, BY REVISION HIP REPLACEMENT, 2018-2032 (USD MILLION)
  • TABLE 99. AMERICAS HIP SURGERY INSTRUMENT SET MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 100. NORTH AMERICA HIP SURGERY INSTRUMENT SET MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 101. NORTH AMERICA HIP SURGERY INSTRUMENT SET MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 102. NORTH AMERICA HIP SURGERY INSTRUMENT SET MARKET SIZE, BY CUPS, 2018-2032 (USD MILLION)
  • TABLE 103. NORTH AMERICA HIP SURGERY INSTRUMENT SET MARKET SIZE, BY REAMERS, 2018-2032 (USD MILLION)
  • TABLE 104. NORTH AMERICA HIP SURGERY INSTRUMENT SET MARKET SIZE, BY SURGICAL TECHNIQUE, 2018-2032 (USD MILLION)
  • TABLE 105. NORTH AMERICA HIP SURGERY INSTRUMENT SET MARKET SIZE, BY MINIMALLY INVASIVE, 2018-2032 (USD MILLION)
  • TABLE 106. NORTH AMERICA HIP SURGERY INSTRUMENT SET MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 107. NORTH AMERICA HIP SURGERY INSTRUMENT SET MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 108. NORTH AMERICA HIP SURGERY INSTRUMENT SET MARKET SIZE, BY REVISION HIP REPLACEMENT, 2018-2032 (USD MILLION)
  • TABLE 109. NORTH AMERICA HIP SURGERY INSTRUMENT SET MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 110. LATIN AMERICA HIP SURGERY INSTRUMENT SET MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 111. LATIN AMERICA HIP SURGERY INSTRUMENT SET MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 112. LATIN AMERICA HIP SURGERY INSTRUMENT SET MARKET SIZE, BY CUPS, 2018-2032 (USD MILLION)
  • TABLE 113. LATIN AMERICA HIP SURGERY INSTRUMENT SET MARKET SIZE, BY REAMERS, 2018-2032 (USD MILLION)
  • TABLE 114. LATIN AMERICA HIP SURGERY INSTRUMENT SET MARKET SIZE, BY SURGICAL TECHNIQUE, 2018-2032 (USD MILLION)
  • TABLE 115. LATIN AMERICA HIP SURGERY INSTRUMENT SET MARKET SIZE, BY MINIMALLY INVASIVE, 2018-2032 (USD MILLION)
  • TABLE 116. LATIN AMERICA HIP SURGERY INSTRUMENT SET MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 117. LATIN AMERICA HIP SURGERY INSTRUMENT SET MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 118. LATIN AMERICA HIP SURGERY INSTRUMENT SET MARKET SIZE, BY REVISION HIP REPLACEMENT, 2018-2032 (USD MILLION)
  • TABLE 119. LATIN AMERICA HIP SURGERY INSTRUMENT SET MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 120. EUROPE, MIDDLE EAST & AFRICA HIP SURGERY INSTRUMENT SET MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 121. EUROPE, MIDDLE EAST & AFRICA HIP SURGERY INSTRUMENT SET MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 122. EUROPE, MIDDLE EAST & AFRICA HIP SURGERY INSTRUMENT SET MARKET SIZE, BY CUPS, 2018-2032 (USD MILLION)
  • TABLE 123. EUROPE, MIDDLE EAST & AFRICA HIP SURGERY INSTRUMENT SET MARKET SIZE, BY REAMERS, 2018-2032 (USD MILLION)
  • TABLE 124. EUROPE, MIDDLE EAST & AFRICA HIP SURGERY INSTRUMENT SET MARKET SIZE, BY SURGICAL TECHNIQUE, 2018-2032 (USD MILLION)
  • TABLE 125. EUROPE, MIDDLE EAST & AFRICA HIP SURGERY INSTRUMENT SET MARKET SIZE, BY MINIMALLY INVASIVE, 2018-2032 (USD MILLION)
  • TABLE 126. EUROPE, MIDDLE EAST & AFRICA HIP SURGERY INSTRUMENT SET MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 127. EUROPE, MIDDLE EAST & AFRICA HIP SURGERY INSTRUMENT SET MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 128. EUROPE, MIDDLE EAST & AFRICA HIP SURGERY INSTRUMENT SET MARKET SIZE, BY REVISION HIP REPLACEMENT, 2018-2032 (USD MILLION)
  • TABLE 129. EUROPE, MIDDLE EAST & AFRICA HIP SURGERY INSTRUMENT SET MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 130. EUROPE HIP SURGERY INSTRUMENT SET MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 131. EUROPE HIP SURGERY INSTRUMENT SET MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 132. EUROPE HIP SURGERY INSTRUMENT SET MARKET SIZE, BY CUPS, 2018-2032 (USD MILLION)
  • TABLE 133. EUROPE HIP SURGERY INSTRUMENT SET MARKET SIZE, BY REAMERS, 2018-2032 (USD MILLION)
  • TABLE 134. EUROPE HIP SURGERY INSTRUMENT SET MARKET SIZE, BY SURGICAL TECHNIQUE, 2018-2032 (USD MILLION)
  • TABLE 135. EUROPE HIP SURGERY INSTRUMENT SET MARKET SIZE, BY MINIMALLY INVASIVE, 2018-2032 (USD MILLION)
  • TABLE 136. EUROPE HIP SURGERY INSTRUMENT SET MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 137. EUROPE HIP SURGERY INSTRUMENT SET MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 138. EUROPE HIP SURGERY INSTRUMENT SET MARKET SIZE, BY REVISION HIP REPLACEMENT, 2018-2032 (USD MILLION)
  • TABLE 139. EUROPE HIP SURGERY INSTRUMENT SET MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 140. MIDDLE EAST HIP SURGERY INSTRUMENT SET MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 141. MIDDLE EAST HIP SURGERY INSTRUMENT SET MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 142. MIDDLE EAST HIP SURGERY INSTRUMENT SET MARKET SIZE, BY CUPS, 2018-2032 (USD MILLION)
  • TABLE 143. MIDDLE EAST HIP SURGERY INSTRUMENT SET MARKET SIZE, BY REAMERS, 2018-2032 (USD MILLION)
  • TABLE 144. MIDDLE EAST HIP SURGERY INSTRUMENT SET MARKET SIZE, BY SURGICAL TECHNIQUE, 2018-2032 (USD MILLION)
  • TABLE 145. MIDDLE EAST HIP SURGERY INSTRUMENT SET MARKET SIZE, BY MINIMALLY INVASIVE, 2018-2032 (USD MILLION)
  • TABLE 146. MIDDLE EAST HIP SURGERY INSTRUMENT SET MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 147. MIDDLE EAST HIP SURGERY INSTRUMENT SET MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 148. MIDDLE EAST HIP SURGERY INSTRUMENT SET MARKET SIZE, BY REVISION HIP REPLACEMENT, 2018-2032 (USD MILLION)
  • TABLE 149. MIDDLE EAST HIP SURGERY INSTRUMENT SET MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 150. AFRICA HIP SURGERY INSTRUMENT SET MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 151. AFRICA HIP SURGERY INSTRUMENT SET MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 152. AFRICA HIP SURGERY INSTRUMENT SET MARKET SIZE, BY CUPS, 2018-2032 (USD MILLION)
  • TABLE 153. AFRICA HIP SURGERY INSTRUMENT SET MARKET SIZE, BY REAMERS, 2018-2032 (USD MILLION)
  • TABLE 154. AFRICA HIP SURGERY INSTRUMENT SET MARKET SIZE, BY SURGICAL TECHNIQUE, 2018-2032 (USD MILLION)
  • TABLE 155. AFRICA HIP SURGERY INSTRUMENT SET MARKET SIZE, BY MINIMALLY INVASIVE, 2018-2032 (USD MILLION)
  • TABLE 156. AFRICA HIP SURGERY INSTRUMENT SET MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 157. AFRICA HIP SURGERY INSTRUMENT SET MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 158. AFRICA HIP SURGERY INSTRUMENT SET MARKET SIZE, BY REVISION HIP REPLACEMENT, 2018-2032 (USD MILLION)
  • TABLE 159. AFRICA HIP SURGERY INSTRUMENT SET MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 160. ASIA-PACIFIC HIP SURGERY INSTRUMENT SET MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 161. ASIA-PACIFIC HIP SURGERY INSTRUMENT SET MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 162. ASIA-PACIFIC HIP SURGERY INSTRUMENT SET MARKET SIZE, BY CUPS, 2018-2032 (USD MILLION)
  • TABLE 163. ASIA-PACIFIC HIP SURGERY INSTRUMENT SET MARKET SIZE, BY REAMERS, 2018-2032 (USD MILLION)
  • TABLE 164. ASIA-PACIFIC HIP SURGERY INSTRUMENT SET MARKET SIZE, BY SURGICAL TECHNIQUE, 2018-2032 (USD MILLION)
  • TABLE 165. ASIA-PACIFIC HIP SURGERY INSTRUMENT SET MARKET SIZE, BY MINIMALLY INVASIVE, 2018-2032 (USD MILLION)
  • TABLE 166. ASIA-PACIFIC HIP SURGERY INSTRUMENT SET MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 167. ASIA-PACIFIC HIP SURGERY INSTRUMENT SET MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 168. ASIA-PACIFIC HIP SURGERY INSTRUMENT SET MARKET SIZE, BY REVISION HIP REPLACEMENT, 2018-2032 (USD MILLION)
  • TABLE 169. ASIA-PACIFIC HIP SURGERY INSTRUMENT SET MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 170. GLOBAL HIP SURGERY INSTRUMENT SET MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 171. ASEAN HIP SURGERY INSTRUMENT SET MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 172. ASEAN HIP SURGERY INSTRUMENT SET MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 173. ASEAN HIP SURGERY INSTRUMENT SET MARKET SIZE, BY CUPS, 2018-2032 (USD MILLION)
  • TABLE 174. ASEAN HIP SURGERY INSTRUMENT SET MARKET SIZE, BY REAMERS, 2018-2032 (USD MILLION)
  • TABLE 175. ASEAN HIP SURGERY INSTRUMENT SET MARKET SIZE, BY SURGICAL TECHNIQUE, 2018-2032 (USD MILLION)
  • TABLE 176. ASEAN HIP SURGERY INSTRUMENT SET MARKET SIZE, BY MINIMALLY INVASIVE, 2018-2032 (USD MILLION)
  • TABLE 177. ASEAN HIP SURGERY INSTRUMENT SET MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 178. ASEAN HIP SURGERY INSTRUMENT SET MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 179. ASEAN HIP SURGERY INSTRUMENT SET MARKET SIZE, BY REVISION HIP REPLACEMENT, 2018-2032 (USD MILLION)
  • TABLE 180. ASEAN HIP SURGERY INSTRUMENT SET MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 181. GCC HIP SURGERY INSTRUMENT SET MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 182. GCC HIP SURGERY INSTRUMENT SET MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 183. GCC HIP SURGERY INSTRUMENT SET MARKET SIZE, BY CUPS, 2018-2032 (USD MILLION)
  • TABLE 184. GCC HIP SURGERY INSTRUMENT SET MARKET SIZE, BY REAMERS, 2018-2032 (USD MILLION)
  • TABLE 185. GCC HIP SURGERY INSTRUMENT SET MARKET SIZE, BY SURGICAL TECHNIQUE, 2018-2032 (USD MILLION)
  • TABLE 186. GCC HIP SURGERY INSTRUMENT SET MARKET SIZE, BY MINIMALLY INVASIVE, 2018-2032 (USD MILLION)
  • TABLE 187. GCC HIP SURGERY INSTRUMENT SET MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 188. GCC HIP SURGERY INSTRUMENT SET MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 189. GCC HIP SURGERY INSTRUMENT SET MARKET SIZE, BY REVISION HIP REPLACEMENT, 2018-2032 (USD MILLION)
  • TABLE 190. GCC HIP SURGERY INSTRUMENT SET MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 191. EUROPEAN UNION HIP SURGERY INSTRUMENT SET MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 192. EUROPEAN UNION HIP SURGERY INSTRUMENT SET MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 193. EUROPEAN UNION HIP SURGERY INSTRUMENT SET MARKET SIZE, BY CUPS, 2018-2032 (USD MILLION)
  • TABLE 194. EUROPEAN UNION HIP SURGERY INSTRUMENT SET MARKET SIZE, BY REAMERS, 2018-2032 (USD MILLION)
  • TABLE 195. EUROPEAN UNION HIP SURGERY INSTRUMENT SET MARKET SIZE, BY SURGICAL TECHNIQUE, 2018-2032 (USD MILLION)
  • TABLE 196. EUROPEAN UNION HIP SURGERY INSTRUMENT SET MARKET SIZE, BY MINIMALLY INVASIVE, 2018-2032 (USD MILLION)
  • TABLE 197. EUROPEAN UNION HIP SURGERY INSTRUMENT SET MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 198. EUROPEAN UNION HIP SURGERY INSTRUMENT SET MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 199. EUROPEAN UNION HIP SURGERY INSTRUMENT SET MARKET SIZE, BY REVISION HIP REPLACEMENT, 2018-2032 (USD MILLION)
  • TABLE 200. EUROPEAN UNION HIP SURGERY INSTRUMENT SET MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 201. BRICS HIP SURGERY INSTRUMENT SET MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 202. BRICS HIP SURGERY INSTRUMENT SET MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 203. BRICS HIP SURGERY INSTRUMENT SET MARKET SIZE, BY CUPS, 2018-2032 (USD MILLION)
  • TABLE 204. BRICS HIP SURGERY INSTRUMENT SET MARKET SIZE, BY REAMERS, 2018-2032 (USD MILLION)
  • TABLE 205. BRICS HIP SURGERY INSTRUMENT SET MARKET SIZE, BY SURGICAL TECHNIQUE, 2018-2032 (USD MILLION)
  • TABLE 206. BRICS HIP SURGERY INSTRUMENT SET MARKET SIZE, BY MINIMALLY INVASIVE, 2018-2032 (USD MILLION)
  • TABLE 207. BRICS HIP SURGERY INSTRUMENT SET MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 208. BRICS HIP SURGERY INSTRUMENT SET MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 209. BRICS HIP SURGERY INSTRUMENT SET MARKET SIZE, BY REVISION HIP REPLACEMENT, 2018-2032 (USD MILLION)
  • TABLE 210. BRICS HIP SURGERY INSTRUMENT SET MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 211. G7 HIP SURGERY INSTRUMENT SET MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 212. G7 HIP SURGERY INSTRUMENT SET MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 213. G7 HIP SURGERY INSTRUMENT SET MARKET SIZE, BY CUPS, 2018-2032 (USD MILLION)
  • TABLE 214. G7 HIP SURGERY INSTRUMENT SET MARKET SIZE, BY REAMERS, 2018-2032 (USD MILLION)
  • TABLE 215. G7 HIP SURGERY INSTRUMENT SET MARKET SIZE, BY SURGICAL TECHNIQUE, 2018-2032 (USD MILLION)
  • TABLE 216. G7 HIP SURGERY INSTRUMENT SET MARKET SIZE, BY MINIMALLY INVASIVE, 2018-2032 (USD MILLION)
  • TABLE 217. G7 HIP SURGERY INSTRUMENT SET MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 218. G7 HIP SURGERY INSTRUMENT SET MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 219. G7 HIP SURGERY INSTRUMENT SET MARKET SIZE, BY REVISION HIP REPLACEMENT, 2018-2032 (USD MILLION)
  • TABLE 220. G7 HIP SURGERY INSTRUMENT SET MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 221. NATO HIP SURGERY INSTRUMENT SET MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 222. NATO HIP SURGERY INSTRUMENT SET MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 223. NATO HIP SURGERY INSTRUMENT SET MARKET SIZE, BY CUPS, 2018-2032 (USD MILLION)
  • TABLE 224. NATO HIP SURGERY INSTRUMENT SET MARKET SIZE, BY REAMERS, 2018-2032 (USD MILLION)
  • TABLE 225. NATO HIP SURGERY INSTRUMENT SET MARKET SIZE, BY SURGICAL TECHNIQUE, 2018-2032 (USD MILLION)
  • TABLE 226. NATO HIP SURGERY INSTRUMENT SET MARKET SIZE, BY MINIMALLY INVASIVE, 2018-2032 (USD MILLION)
  • TABLE 227. NATO HIP SURGERY INSTRUMENT SET MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 228. NATO HIP SURGERY INSTRUMENT SET MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 229. NATO HIP SURGERY INSTRUMENT SET MARKET SIZE, BY REVISION HIP REPLACEMENT, 2018-2032 (USD MILLION)
  • TABLE 230. NATO HIP SURGERY INSTRUMENT SET MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 231. GLOBAL HIP SURGERY INSTRUMENT SET MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 232. UNITED STATES HIP SURGERY INSTRUMENT SET MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 233. UNITED STATES HIP SURGERY INSTRUMENT SET MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 234. UNITED STATES HIP SURGERY INSTRUMENT SET MARKET SIZE, BY CUPS, 2018-2032 (USD MILLION)
  • TABLE 235. UNITED STATES HIP SURGERY INSTRUMENT SET MARKET SIZE, BY REAMERS, 2018-2032 (USD MILLION)
  • TABLE 236. UNITED STATES HIP SURGERY INSTRUMENT SET MARKET SIZE, BY SURGICAL TECHNIQUE, 2018-2032 (USD MILLION)
  • TABLE 237. UNITED STATES HIP SURGERY INSTRUMENT SET MARKET SIZE, BY MINIMALLY INVASIVE, 2018-2032 (USD MILLION)
  • TABLE 238. UNITED STATES HIP SURGERY INSTRUMENT SET MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 239. UNITED STATES HIP SURGERY INSTRUMENT SET MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 240. UNITED STATES HIP SURGERY INSTRUMENT SET MARKET SIZE, BY REVISION HIP REPLACEMENT, 2018-2032 (USD MILLION)
  • TABLE 241. UNITED STATES HIP SURGERY INSTRUMENT SET MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 242. CHINA HIP SURGERY INSTRUMENT SET MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 243. CHINA HIP SURGERY INSTRUMENT SET MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 244. CHINA HIP SURGERY INSTRUMENT SET MARKET SIZE, BY CUPS, 2018-2032 (USD MILLION)
  • TABLE 245. CHINA HIP SURGERY INSTRUMENT SET MARKET SIZE, BY REAMERS, 2018-2032 (USD MILLION)
  • TABLE 246. CHINA HIP SURGERY INSTRUMENT SET MARKET SIZE, BY SURGICAL TECHNIQUE, 2018-2032 (USD MILLION)
  • TABLE 247. CHINA HIP SURGERY INSTRUMENT SET MARKET SIZE, BY MINIMALLY INVASIVE, 2018-2032 (USD MILLION)
  • TABLE 248. CHINA HIP SURGERY INSTRUMENT SET MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 249. CHINA HIP SURGERY INSTRUMENT SET MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 250. CHINA HIP SURGERY INSTRUMENT SET MARKET SIZE, BY REVISION HIP REPLACEMENT, 2018-2032 (USD MILLION)
  • TABLE 251. CHINA HIP SURGERY INSTRUMENT SET MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)